Alpha Co., Ltd.
Alpha Co., Ltd. (4760.T) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Alpha Co., Ltd. (4760.T), featuring income statements, balance sheets, and cash flow data.
Alpha Co., Ltd. (4760.T) Income Statement & Financial Overview
Analyze Alpha Co., Ltd.’s 4760.T earnings with segmented quarterly and yearly financial statement figures.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $1.51B | $1.64B | $1.44B | $1.48B |
Cost of Revenue | $901.82M | $988.00M | $854.38M | $900.04M |
Gross Profit | $606.88M | $656.00M | $588.09M | $582.75M |
Gross Profit Ratio | $0.40 | $0.40 | $0.41 | $0.39 |
R&D Expenses | $0.00 | $0.00 | $27.45M | $39.00M |
SG&A Expenses | $558.81M | $562.00M | $571.77M | $581.00M |
Operating Expenses | $558.81M | $563.00M | $599.23M | $580.42M |
Total Costs & Expenses | $1.46B | $1.55B | $1.45B | $1.48B |
Interest Income | $385000.00 | $0.00 | $344000.00 | $3.00M |
Interest Expense | $3.33M | $0.00 | $2.80M | $2.79M |
Depreciation & Amortization | $2.89M | $2.50M | $3.21M | $3.00M |
EBITDA | $52.63M | $96.50M | -$11.70M | $37.83M |
EBITDA Ratio | $0.03 | $0.06 | -$0.008 | $0.03 |
Operating Income | $48.08M | $93.00M | -$13.02M | $2.33M |
Operating Income Ratio | $0.03 | $0.06 | -$0.009 | $0.002 |
Other Income/Expenses (Net) | -$1.67M | -$3.00M | -$5.77M | $29.94M |
Income Before Tax | $46.41M | $90.00M | -$18.79M | $32.27M |
Income Before Tax Ratio | $0.03 | $0.05 | -$0.01 | $0.02 |
Income Tax Expense | $24.44M | $22.00M | $1.09M | $1.24M |
Net Income | $21.97M | $68.00M | -$19.88M | $31.02M |
Net Income Ratio | $0.01 | $0.04 | -$0.01 | $0.02 |
EPS | $27.33 | $84.57 | -$24.73 | $38.55 |
Diluted EPS | $27.33 | $84.57 | -$24.73 | $38.55 |
Weighted Avg Shares Outstanding | $804040.00 | $804040.00 | $804044.00 | $804056.00 |
Weighted Avg Shares Outstanding (Diluted) | $804040.00 | $804040.00 | $804044.00 | $804056.00 |
Over the past four quarters, Alpha Co., Ltd. demonstrated steady revenue growth, increasing from $1.48B in Q3 2024 to $1.51B in Q2 2025. Operating income reached $48.08M in Q2 2025, maintaining a consistent 3% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $52.63M, reflecting operational efficiency. Net income dropped to $21.97M, with EPS at $27.33. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan